<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04065451</url>
  </required_header>
  <id_info>
    <org_study_id>1908473351</org_study_id>
    <nct_id>NCT04065451</nct_id>
  </id_info>
  <brief_title>Effect of Epinephrine on Post-polypectomy Pain</brief_title>
  <official_title>Effect of Epinephrine on Immediate Post-polypectomy Pain in Colorectal Lesions Larger Than 20 mm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indiana University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indiana University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Epinephrine is widely used in endoscopic mucosal resection of large polyps to prevent&#xD;
      post-polypectomy bleeding. No previous studies looked at increase in immediate&#xD;
      post-polypectomy pain with the use of epinephrine.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 6, 2020</start_date>
  <completion_date type="Actual">August 17, 2021</completion_date>
  <primary_completion_date type="Actual">August 17, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Immediate post-polypectomy pain</measure>
    <time_frame>30 minutes after the procedure</time_frame>
    <description>Pain related by the participant on a 0-100 visual analog scale; patients will be asked to mark their pain level on a straight vertical line 100 mm long and this point will be measured with a ruler for pain score. Possible values are zero- indicating no pain at all to 100-indicating worst imaginable pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>en bloc resection</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>yes or no for complete removal of the polyp en bloc</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sydney resection quotient</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>size of the polyp in mm divided by the number of pieces the polyps is removed in</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of the mound</measure>
    <time_frame>During the colonoscopy procedure</time_frame>
    <description>endoscopist impression of lift provided by the submucosal injection, excellent, good or inadequate</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>Epinephrine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Epinephrine in the submucosal injection fluid (1:200,000)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No epinephrine</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Submucosal injection fluid without epinephrine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Epinephrine in the submucosal injection fluid</description>
    <arm_group_label>Epinephrine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          1. Patients aged 18 years and over&#xD;
&#xD;
          2. Patients scheduled for treatment of large (â‰¥ 20 mm) colorectal polyps&#xD;
&#xD;
          3. Able to sign informed consent&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          1. Patients previously enrolled in the study&#xD;
&#xD;
          2. Pedunculated polyps&#xD;
&#xD;
          3. Polyps not amenable to endoscopic resection&#xD;
&#xD;
          4. Patients allergic or sensitive to epinephrine&#xD;
&#xD;
          5. Patients with coronary artery disease who have had a myocardial infarction in the past&#xD;
             year, or had coronary stenting in the past year, or had angina in the past year.&#xD;
&#xD;
          6. Patients electing anesthesia other than monitored anesthesia care with propofol (MAC)&#xD;
             for colonoscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Douglas K Rex, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IU</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Indiana University Hospital</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 15, 2019</study_first_submitted>
  <study_first_submitted_qc>August 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2019</study_first_posted>
  <last_update_submitted>September 17, 2021</last_update_submitted>
  <last_update_submitted_qc>September 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indiana University</investigator_affiliation>
    <investigator_full_name>Douglas K. Rex</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epinephrine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

